Transplant strategies in relapsed/refractory Hodgkin lymphoma.

about

Transplant strategies in relapsed/refractory Hodgkin lymphoma.

Item

http://www.wikidata.org/entity/Q52676516

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Transplant strategies in relapsed/refractory Hodgkin lymphoma.

@en

Transplant strategies in relapsed/refractory Hodgkin lymphoma.

@nl

type

Item

label

Transplant strategies in relapsed/refractory Hodgkin lymphoma.

@en

Transplant strategies in relapsed/refractory Hodgkin lymphoma.

@nl

prefLabel

Transplant strategies in relapsed/refractory Hodgkin lymphoma.

@en

Transplant strategies in relapsed/refractory Hodgkin lymphoma.

@nl

P1476

Transplant strategies in relapsed/refractory Hodgkin lymphoma.

@en

P2093

Craig H Moskowitz

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.

Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease.

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma.

Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study.

Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies.

Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma.

Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.

P304

1689-1697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2017-09-772673

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

Gunjan L Shah

P577

2018-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29500170

http://www.w3.org/2001/XMLSchema#string

P932

5897866

http://www.w3.org/2001/XMLSchema#string